Author response for "The Effect of Asfotase Alfa on Plasma and Urine Pyrophosphate Levels and Pseudofractures in a Patient With Adult-Onset Hypophosphatasia"
Naoko Hidaka(University of Tokyo Hospital), Nobuaki Ito(University of Tokyo Hospital), So Watanabe(University of Tokyo Hospital), Keiichi Osaki(Matsushita Memorial Hospital), Masaomi Nangaku(The University of Tokyo), Takashi Sekiyama(Panasonic (Japan)), Hajime Katô(University of Tokyo Hospital), Yoshitomo Hoshino(University of Tokyo Hospital), Hiroaki Murata(University of Nagasaki), Yuka Kinoshita(University of Tokyo Hospital), Noriko Makita(University of Occupational and Environmental Health Japan), Soichiro Kimura(Kinjo Gakuin University), Toshimi Michigami(Osaka International Cancer Institute), Takashi Sunouchi(University of Tokyo Hospital), Kanako Tachikawa(Osaka Women's and Children's Hospital)
Cited by 0
Related Papers
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
Glutaredoxin Exerts an Antiapoptotic Effect by Regulating the Redox State of Akt
|Journal of Biological Chemistry|2003|316
Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period
|Calcified Tissue International|2019|160
Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease—Improving Global Outcomes (KDIGO) Controversies Conference
|Kidney International|2017|149
X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment
|Endocrine Reviews|2018|148